Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti–TNF-α Agents on B Lymphocytes: A Review of the Literature
Ozlem Pala, Alain Diaz, Bonnie B. Blomberg, et al.
Clinical Therapeutics (2018) Vol. 40, Iss. 6, pp. 1034-1045
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis
Reda Ben Mrid, Najat Bouchmaa, Hassan Ainani, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113126-113126
Open Access | Times Cited: 86
Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
Margaret M. Lowe, Haley B. Naik, Sean Clancy, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 105
Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses
Silvia Menegatti, Elisabetta Bianchi, Lars Rogge
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 82
Structural changes, and anti-inflammatory, anti-cancer potential of polysaccharides from multiple processing of Rehmannia glutinosa
Mei‐Kuang Lu, Chia‐Chuan Chang, Chi‐Hsein Chao, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 621-632
Closed Access | Times Cited: 53
Efficacy and mechanism of the Ermiaosan Series of Formulas for rheumatoid arthritis based on chinmedomics strategy
Hongda Liu, Ling Bing Kong, Dongdong Cao, et al.
Phytomedicine (2024) Vol. 132, pp. 155903-155903
Closed Access | Times Cited: 10
Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
Shyi‐Jou Chen, Gu‐Jiun Lin, Jing-Wun Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 53
Potential Anti-Rheumatoid Arthritis Activities and Mechanisms of Ganoderma lucidum Polysaccharides
Meng Meng, Jialin Yao, Yukun Zhang, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2483-2483
Open Access | Times Cited: 15
Role of miRNAs in Rheumatoid Arthritis Therapy
Yiping Zhang, Mei-wen Yang, Hongyan Xie, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1749-1749
Open Access | Times Cited: 14
Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Tomasz Wysocki, Agnieszka Paradowska‐Gorycka
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2366-2366
Open Access | Times Cited: 20
The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients
Safieh Firouzi, Naseh Pahlavani, Jamshid Gholizadeh Navashenaq, et al.
Clinical Nutrition Open Science (2022) Vol. 44, pp. 144-154
Open Access | Times Cited: 19
Development and validation of a prognostic nomogram for predicting mortality risk in adult rheumatoid arthritis: an analysis of NHANES 1999–2018 data
Xiao Chen, Haibo Gong, Jing Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-κB pathways in B and T cells
Xinming Wang, Xiaoyun Chen, Wei Huang, et al.
Inflammopharmacology (2018) Vol. 27, Iss. 3, pp. 487-502
Closed Access | Times Cited: 28
Inhibitory role of long non‐coding RNA OIP5‐AS1 in rheumatoid arthritis progression through the microRNA‐448–paraoxonase 1–toll‐like receptor 3–nuclear factor κB axis
Pingying Qing, Yi Liu
Experimental Physiology (2020) Vol. 105, Iss. 10, pp. 1708-1719
Open Access | Times Cited: 26
Developing cerium modified gold nanoclusters for the treatment of advanced-stage rheumatoid arthritis
Sen Lin, Wei Gao, Jiachen Sun, et al.
Materials Today Bio (2022) Vol. 15, pp. 100331-100331
Open Access | Times Cited: 14
An emerging role of interleukin-23 in rheumatoid arthritis
Na Yuan, Guimei Yu, Di Liu, et al.
Immunopharmacology and Immunotoxicology (2019) Vol. 41, Iss. 2, pp. 185-191
Closed Access | Times Cited: 24
From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment
Nan Zhang, Mengru Li, Ziye Hou, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 107-121
Closed Access | Times Cited: 13
Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy
Huihui Wu, Songsen Su, Yifeng Wu, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106933-106933
Closed Access | Times Cited: 19
Adiponectin Enhances B-Cell Proliferation and Differentiation via Activation of Akt1/STAT3 and Exacerbates Collagen-Induced Arthritis
Nan Che, Xiaoxuan Sun, Lei Gu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs
Åsa K. Hedman, Eitan Winter, Niyaz Yoosuf, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Cutting Edge: Processing of Oxidized Peptides in Macrophages Regulates T Cell Activation and Development of Autoimmune Arthritis
Min Yang, Claus Haase, Johan Viljanen, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 12, pp. 3937-3942
Open Access | Times Cited: 21
Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients
Zafar Mahmood, Marc Schmalzing, Thomas Dörner, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Distinct Longitudinal Changes in Immunoglobulin G N-Glycosylation Associate with Therapy Response in Chronic Inflammatory Diseases
Jerko Štambuk, Frano Vučković, Siniša Habazin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8473-8473
Open Access | Times Cited: 9
Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs
Ling Zhang, Yihang Zhang, Jihong Pan
Intractable & Rare Diseases Research (2021) Vol. 10, Iss. 3, pp. 154-164
Open Access | Times Cited: 12
TNF-α Inhibitors from Natural Compounds: An Overview, CADD Approaches, and their Exploration for Anti-inflammatory Agents
Edeildo Ferreira da Silva‐Júnior, Igor José dos Santos Nascimento
Combinatorial Chemistry & High Throughput Screening (2021) Vol. 25, Iss. 14, pp. 2317-2340
Closed Access | Times Cited: 12
Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis
M. Li, Jianchun Mao, Yi Zhun Zhu
Advances in experimental medicine and biology (2021), pp. 161-179
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top